Abstract
Persistent pulmonary hypertension of the newborn (PPHN) is a common neonatal condition in newborns admitted to the neonatal intensive care units (NICUs). PPHN has still a high mortality and morbidity. Inhaled nitric oxide (iNO) is the first line vasodilator therapy for PPHN in high income countries. In low-to-middle income countries (LMICs), availability of iNO remains scarce and expensive. The purpose of this scoping review was to evaluate the current existing literature for milrinone therapy in PPHN and to identify the knowledge gaps in milrinone use in infants with PPHN. The available evidence for milrinone remains limited both as monotherapy and as an adjuvant to iNO. The studies were heterogeneous, conducted in different settings, with different populations and more importantly the endpoints of these trials were short-term outcomes such as changes in oxygenation and blood pressure. Large prospective studies investigating long-term outcomes, mortality, and the need for Extracorporeal membrane oxygenation (ECMO) are warranted. Randomized controlled trials with milrinone as monotherapy are needed in LMICs where iNO availability remains limited.
Impact
-
Milrinone has a potential role in the management of PPHN both as an adjuvant to iNO as well as a monotherapy.
-
This scoping review identified the problems existing in the published literature on milrinone and the barriers to generalization of these results.
-
Multi-centre randomized controlled trials on milrinone, especially involving centers from low- and middle-income countries are needed, where it can be evaluated as first-line pulmonary vasodilator therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data used in the review is already available in public domain.
References
Lakshminrusimha, S. & Keszler, M. Persistent pulmonary hypertension of the newborn. Neoreviews 16, e680–e692 (2015).
Zhou, R., Zheng, Y.-N., Zhang, X.-Y. & Cheng, Y.-Y. A meta-analysis of the risk factors of persistent pulmonary hypertension in newborns. Front. Pediatr. 9, 659137 (2021).
Galambos, C. et al. Phenotype characterisation of Tbx4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur. Respir. J. 54, 1801965 (2019).
Martinho, S., Adão, R., Leite-Moreira, A. F. & Brás-Silva, C. Persistent pulmonary hypertension of the newborn: pathophysiological mechanisms and novel therapeutic approaches. Front. Pediatr. 8, 342 (2020).
Davidson, D. et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 101, 325–334 (1998).
Clark, R. H. et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N. Engl. J. Med. 342, 469–474 (2000).
Baquero, H., Soliz, A., Neira, F., Venegas, M. E. & Sola, A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117, 1077–1083 (2006).
Vargas-Origel, A. et al. The use of sildenafil in persistent pulmonary hypertension of the newborn. Am. J. Perinatol. 27, 225–230 (2010).
McNamara, P. J., Shivananda, S. P., Sahni, M., Freeman, D. & Taddio, A. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr. Crit. Care Med. 14, 74–84 (2013).
Bassler, D., Choong, K., McNamara, P. & Kirpalani, H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol. Neonate 89, 1–5 (2006).
Tricco, A. C. et al. Prisma extension for scoping reviews (PRISMA-Scr): checklist and explanation. Ann. Intern. Med. 169, 467–473 (2018).
Imam, S. S., El-Farrash, R. A., Taha, A. S. & Saleh, G. A. Milrinone versus sildenafil in treatment of neonatal persistent pulmonary hypertension: a randomized control trial. J. Cardiovasc. Pharmacol. 80, 746–752 (2022).
El-Ghandour, M., Hammad, B., Ghanem, M. & Antonios, M. A. M. Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension in resource-limited settings: results of a randomized, double-blind trial. Pediatr. Drugs 22, 685–693 (2020).
Bagheri, M. M., Ebrahimpour, M., Amirzadeh, R. & Derakhshan, R. Comparison of the efficacy of milrinone injection versus milrinone plus oral sildenafil in newborns with pulmonary arterial hypertension. J. Kerman Univ. Med. Sci. 28, 1–9 (2021).
Rahman, M., Nupur, N. R., Mamun, M. A. A. & Hossain, M. M. Comparison of efficacy between sildenafil alone and sildenafil with milrinone for treatment of persistent pulmonary hypertension of the newborn. Scholars J. Appl. Med. Sci. 9, 1525–1532 (2021).
Sardar, S., Pal, S. & Mishra, R. A retrospective study on the profile of persistent pulmonary hypertension of newborn in a tertiary care unit of Eastern India. J. Clin. Neonatol. 9, 18–26 (2020).
James, A. T., Corcoran, J. D., McNamara, P. J., Franklin, O. & El-Khuffash, A. F. The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol. Young 26, 90–99 (2016).
McNamara, P. J., Laique, F., Muang-In, S. & Whyte, H. E. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J. Crit. Care 21, 217–222 (2006).
Dillard, J., Pavlek, L. R., Korada, S. & Chen, B. Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving ino responsiveness. J. Perinatol. 42, 37–44 (2022).
El-Khuffash, A. et al. The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (Mint 1). J. Perinatol. 43, 168–173 (2023).
Choobdar, F. A. et al. Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: a randomized clinical trial. Pediatr. Pulmonol. 58, 2132–2139 (2023).
Hoffman, T. M. et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107, 996–1002 (2003).
Lakshminrusimha, S. et al. Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices. Matern. Health Neonatol. Perinatol. 3, 27 (2017).
Schouten, E. et al. Standardized outcome measures for preterm and hospitalized neonates: an ICHOM standard set. Neonatology 119, 443–454 (2022).
Author information
Authors and Affiliations
Contributions
Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data: R.G., Y.S. Drafting the article or revising it critically for important intellectual content: R.G., D.M., P.T., S.D., A.P., L.O., J.M., A.L., R.R., B.K., Y.S. All authors approved of the version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Galis, R., Mudura, D., Trif, P. et al. Milrinone in persistent pulmonary hypertension of newborn: a scoping review. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03234-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-024-03234-z